ProQR Therapeutics (PRQR) Net Cash Flow Growth (1y) (2014 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -100.88% |
| Sep 30, 2022 | -431.09% |
| Jun 30, 2022 | -118.65% |
| Mar 31, 2022 | -124.52% |
| Dec 31, 2021 | 351.13% |
| Sep 30, 2021 | 386.70% |
| Jun 30, 2021 | 875.25% |
| Mar 31, 2021 | -65,603.15% |
| Dec 31, 2020 | -133.09% |
| Sep 30, 2020 | 136.72% |
| Jun 30, 2020 | 9.17% |
| Mar 31, 2020 | 99.88% |
| Dec 31, 2019 | 451,869.13% |
| Sep 30, 2019 | -110.78% |
| Jun 30, 2019 | -92.12% |
| Mar 31, 2019 | -3,560,227.31% |
| Dec 31, 2018 | -130.13% |
| Sep 30, 2018 | 254,392,015.15% |
| Jun 30, 2018 | 31.94% |
| Mar 31, 2018 | -96.69% |
| Dec 31, 2017 | 100.08% |
| Sep 30, 2017 | 100.29% |
| Dec 31, 2016 | -49.80% |
| Sep 30, 2016 | -78.10% |
| Dec 31, 2015 | -283.00% |
| Sep 30, 2015 | -100.01% |
| Mar 31, 2015 | -125.78% |
| Dec 31, 2014 | -321.17% |
| Sep 30, 2014 | 9,519.72% |